Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy-Reference-Cited by-同舟云学术

Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy

Published:2013-07 Issue:1 Volume:62 Page:21-29
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kini Annapoorna S.,Baber Usman,Kovacic Jason C.,Limaye Atul,Ali Ziad A.,Sweeny Joseph,Maehara Akiko,Mehran Roxana,Dangas George,Mintz Gary S.,Fuster Valentin,Narula Jagat,Sharma Samin K.,Moreno Pedro R.

Funder

InfraReDx, Inc

Boston Scientific

St. Jude Medical, Inc

National Institutes of Health

AstraZeneca

Medicines Company

Bristol-Myers Squibb

Sanofi-Aventis

Eli Lilly and Co.

Daiichi Sankyo, Inc

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association;Weintraub;Circulation,2011

2. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation;Smith;J Am Coll Cardiol,2011

3. Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial;Bulbulia;Lancet,2011

4. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?;Schonbeck;Circulation,2004

5. Effect of two intensive statin regimens on progression of coronary disease;Nicholls;N Engl J Med,2011

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Hybrid Intracoronary Imaging Technologies and Their Applications in Clinical Practice and Research;JACC: Cardiovascular Interventions;2024-09

2. Very short-term effects of a single dose of a proprotein convertase subtilisin/kexin 9 inhibitor before percutaneous coronary intervention: A single-arm study;Atherosclerosis;2024-09

3. Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with 18F–NaF PET-CT;Atherosclerosis;2024-08

4. The clinical relevance of the reversal of coronary atherosclerotic plaque;European Journal of Internal Medicine;2024-08

5. Unraveling the Rapid Progression of Non-Target Lesions: Risk Factors and the Therapeutic Potential of PCSK9 Inhibitors in Post-PCI Patients;2024-07-26